2Obara W, Mizutani Y, Oyama C, et al. Prospective study of combined treatment with interferon alpha and active vitamin D3 for Japanese patients with metastatic renal cell carcinoma. Int J Urol, 2008, 15: 794-799.
3Gupta K, Miller JD, Li JZ, et al. Epidemiologic and socioe conomic burden of metastatic renal cell carcinoma (mRCC) : a literature review. Cancer Treat Rev, 2008, 34:193-205.
4Taari K, Perttila I, Nisen H. Laparoscopic versus open nephrectomy for renal cell carcinoma? Scand J Surg, 2004, 93:132-136.
5Rubinstein M, Moinzadeh A, Colombo JR Jr. Energy sources for laparoscopic partial nephrectomy critical appraisal. Int Braz J Urol, 2007, 33:3-10.
6Chapman TN, Sharma S, Zhang S. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma. Urology, 2008, 71:287-291.
7Godoy G, O'Malley RL, Taneja SS. Lymph node dissection during the surgical treatment of renal cancer in the modern era. Int Braz J Urol, 2008, 34: 132-142.
8Margulis V, Wood CG. The role of lymph node dissection in renal cell carcinoma: the pendulum swings back. Cancer J, 2008, 14: 308-314.
9Leibovich BC, Blute ML. Lymph node dissection in the management of renal cell carcinoma. Urol Clin North Am, 2008, 35: 673-678.
10Blom JH, van Poppel H, Marechal JM, et al. Radical nephrectomy with and without lymph node dissection: Final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol, 2009, 55:28-34.
